Загрузка...
Targeting of interleukin-17 in the treatment of psoriasis
“Psoriasis” is a chronic immune-mediated inflammatory disorder with epidermal hyperplasia. There is some evidence that the cytokine interleukin-17A (often known as IL-17), which is mainly produced by Th17 cells, has a role in the pathogenesis of psoriasis. “IL-17” is a pro-inflammatory cytokine main...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4168861/ https://ncbi.nlm.nih.gov/pubmed/25246805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S67534 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|